RecruitingNCT06080737
Long Term Effects of Awake Prone Positioning in COVID-19 ICU Patients
Effects of Awake Prone Positioning on Long-term Quality of Life in Patients Managed in the ICU Under Nasal High Flow for SARS-CoV2 Pneumonia, a Cohort Study Nested Within a Randomized Trial
Sponsor
University Hospital, Tours
Enrollment
300 participants
Start Date
May 3, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
Long term follow up of patients included in a randomized controlled trial evaluating awake prone positioning among patients suffering SARS-CoV2 pneumonia (NCT04358939)
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Patients included in the randomized meta-trial evaluating awake prone position versus control among COVID-19 patients on high-flow nasal oxygen therapy (Ehrmann 2021).
- Patients alive at D28
- No opposition to participate in the research which evaluates mortality and quality of life by telephone interview.
Exclusion Criteria4
- Patients lost to follow-up after 28 days.
- Withdrawal of consent from randomized meta-trial by patient
- Vulnerable person: safeguard of justice, curatorship, or guardianship
- Patients refusing to answer telephone questionnaire.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERquality of life questionnaire
telephone interview to assess mortality and quality of life in the population included in a trial
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06080737